Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for MGTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 215.57M
March 31, 2026 -58.13M
December 31, 2025 -5.793M
September 30, 2025 -40.56M
June 30, 2025 2.96M
March 31, 2025 33.10M
December 31, 2024 67.83M
September 30, 2024 95.74M
June 30, 2024 80.04M
March 31, 2024 121.73M
December 31, 2023 138.18M
September 30, 2023 91.89M
June 30, 2023 123.53M
March 31, 2023 90.22M
December 31, 2022
September 30, 2022 122.67M
June 30, 2022 141.97M
Date Value
March 31, 2022 161.28M
December 31, 2021 185.40M
September 30, 2021 187.84M
June 30, 2021 205.72M
March 31, 2021 220.79M
December 31, 2020 238.56M
September 30, 2020 179.09M
June 30, 2020 172.77M
March 31, 2020 184.92M
December 31, 2019 190.80M
September 30, 2019 194.89M
June 30, 2019 129.56M
March 31, 2019 144.42M
December 31, 2018 81.06M
September 30, 2018 96.34M
June 30, 2018 108.47M
March 31, 2018 36.44M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Xencor, Inc. 503.23M
UroGen Pharma Ltd. -132.40M
IDEAYA Biosciences, Inc. 1.199B
ACADIA Pharmaceuticals, Inc. 1.307B
Alnylam Pharmaceuticals, Inc. 1.354B

Shareholders Equity (Quarterly) Related Metrics